| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |